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1. Introduction 
The transmembrane glycoprotein G of vesicular 
stomatitis virus (VW) has provided a model for 
understanding the sequence of events involved in the 
biogenesis of integral membrane glycoproteins [ 11. 
Studies in vitro on the biogenesis of G protein showed 
that glycosylation and insertion into microsomal 
membrane vesicles were a co-translational event 
12-51 which also involved the proteolytic cleavage of 
an NH?-terminal signal peptide containing 16 amino 
acids of which -70% are hydrophobic [6,7]. In the 
VW-infected cell the nonglycosylated G protein 
(GTM) synthesized in the presence of the glycosyla- 
tion inhibitor tunicamycin (TM) [8] was unable to 
migrate to the plasma membrane [9]. The non-glyco- 
sylated G protein had altered solubility and aggre- 
gated at an elevated temperature presumably due to 
an altered conformation [9-121. In vitro studies have 
shown that the non-glycosylated protein could be 
inserted into microsomal membrane vesicles [ 13,141 
but it was not established if the hydrophobic signal 
peptide was cleaved in the absence of glycosylation. 
Thus, the observed increase in aggregation of GTM 
could be due both to the presence of the hydropho- 
bic signal peptide and to an altered conformation. 
sesses the same NH?-terminal sequence as the glyco- 
sylated G indicating that the signal peptide was cleaved 
in the absence of glycosylation. 
2. Experimental 
Here, we show that the non-glycosylated GTM pos- 
Abbreviations: VW, vesicular stomatitis virus; G, fully 
glycosylated viral glycoproteins (_kfr 69 000); GTM, non- 
glycosylated G (M, 63 000) synthesized in the presence of 
tunicamycin; TM, tunicamycin; G,, partially glycosylated G 
@fr 67 000) synthesized in vitro in the presence of micro- 
somal membrane; G,, nonglycosylated primary translation 
(M, 63 000) of G mRNA synthesized in vitro in the absence 
of membrane; L, N, NS and M, non-glycosylated VS viral 
proteins; M,, relative molecular mass 
Plaque-purified VSV (Indiana HR-LT) and BHK-21 
and HeLa cells were grown as in [2,3]. BHK-21 cells 
in monolayer were treated with TM (Lilly Co. Ltd, 
Indianapolis IN) at 2 pg/ml for 1 h and were infected 
with VSV at m.o.i. 30-50. After incubation in the 
presence of TM for 4.5 h, infected cells were labelled 
either with [35S]methionine (50 @i/ml) or a single 
[ 3H] amino acid (100 pg/ml) for 20 min. At the end 
of the labelling the cells were washed and suspended 
in a homogenizing buffer (0.01 M Tris (pH 7.5)- 
0.02 M KCl-O.001 M MgCl?) and disrupted in a 
Dounce homogenizer. A post-nuclear supernatant 
fraction (S4) was obtained by centrifuging the extract 
at 4000 X g for 5 min. The labelled virus-specific pro- 
teins in the S4 extract were separated on a 10% acryl- 
amide slab gel containing 0.1% SDS [2,3]. The radio- 
active proteins were extracted and isolated from the 
slab gel as in [ 161. The G protein samples labelled 
with [35S]methionine and the individual [3H]amino 
acids were combined and analyzed for partial NH2- 
terminal sequence. Sequential Edman degradation in 
a Beckman 890C sequencer was performed as in [6]. 
In vitro protein synthesis using VSV-specific 
mRNA and ribosomal extracts containing microsomal 
membranes from HeLa cells were done as in [2,3,6]. 
A ribosomal extract deficient in endogenous oligo- 
saccharide donor present in the microsomal mem- 
brane was prepared from HeLa cells grown for 4 h in 
the presence of TM at 5 pg/ml. 
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3. Results and discussion 
In agreement with [13,14] we found that the non- 
glycosylated protein GT, synthesized in the presence 
of TM has a decreased Mr - 63 000 compared to 
M, 69 000 for G protein (fig.l(c,a)) and GT, was 
inserted in the microsomal membrane vesicle as 
assayed by protection from proteolytic digestion 
(fig.l(d)). A polypeptide of -63 000 Mr was also syn- 
thesized in vitro when VSV-mRNA was translated in 
a ribosomal extract containing microsomal mem- 
branes from HeLa cells grown in the presence of TM 
(fig.l(e)) in comparison to the partially glycosylated 
precursor Gz (M, 67 000) synthesized in vitro in an 
extract derived from cells not treated with TM 
(fig.l(f)) [2-41. 
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Fig.1. Synthesis of nonglycosylated GTM. The autoradio- 
gram shows [ 55S]methionine-labelled intracellular VSV pro- 
teins (L, G, NS, N and M): (a) control extract;(b) control 
extract + 50 pg/ml trypsin; (c) extract from TM-treated cells; 
(d) extracts from TM-treated cells + 50 @g/ml trypsin; (e) 
[55S]methionine-labelled VSV marker; (f,g) from a separate 
gel showing in vitro synthesized proteins by HeLa cell extracts 
from control cells and TM-treated cells, respectively. G, rep- 
resents an in vitro synthesized partially glycosylated form of 
G and G, * represents G, with its COOH-terminus digested by 
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Fig.2. Partial NH-terminal sequence analysis of G and GTM. 
G and GTM labelled with [35S]Met (500 Ci/mmol), [‘HJLeu 
(30 Ci/mmol), [‘H]Lys(30 Ci/mmol), [3H]Phe (SO Ci/mmol), 
[‘HIPro (30 Ci/mmol), [‘H]Val(60 Ci/mmol) and [sH]Gly 
(12 Ci/mmol), was isolated and sequenced by automatic 
Edman degradation [6]. The radioactivity recovered in the 
fractions was identified by thin-layer chromatography on 
silica gel plates [6] and was plotted against cycle of degrada- 
tion. The yield of radioactive lysine in the first cycle of deg- 
radation was lower than the lysine released in cycle 11 and 
14. Similar yields of non-radioactive lysine was also observed 
during sequencing of non-radioactive G protein (unpublished). 
To determine if CT, contains the signal peptide 
we isolated CT, from VSV-infected cells labelled 
with [35S]methionine and [3H]leucine, lysine, valine, 
proline and phenylalanine in the presence of TM and 
analyzed the NH&erminal sequence by automatic 
Edman degradation. For comparison G protein labelled 
with the same amino acids but in the absence of TM 
was isolated from VSV-infected cells and its NH,-ter- 
minal sequence determined. The partial NH2-terminal 
L%HE - %&EPac - - - LYSGCV - - 
G L&IE - - VALPHEPRC - - !'LYSGLY - - 
c7M L:ShE - - VALhEPRO - - 'LYS 
Fig.3. Comparison of the partial NH,-terminal amino acid 
sequence of in vitro synthesized G, [6,15] and in vitro syn- 
thesized G and GTM. 
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sequence of GT, and G were identical (fig.2). A com- 
parison of the NHTterminal sequences of GT,, G and 
the non-glycosylated primary translation product G, 
[6,5] (fig.3) shows that the signal peptide of 16 amino 
acid present in Gr is absent in both GT, and G 
establishing that the signal peptide is correctly cleaved 
in the absence of glycosylation. 
The altered physical properties of non-glycosylated 
G presumably due to a different conformation of the 
polypeptide is thus, not due to the presence of the 
hydrophobic signal peptide or an incorrect cleavage 
of the signal peptide. 
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